Blood vessels and adjacent cells form perivascular stem cell niches in adult tissues. In this perivascular niche, a stem cell with mesenchymal characteristics was recently identified in some adult somatic tissues. These cells are pericytes that line the microvasculature, express mesenchymal markers and differentiate into mesodermal lineages but might even have the capacity to generate tissue-specific cell types. Here, we isolated, purified and characterized a previously unrecognized progenitor population from two different regions in the adult human brain, the ventricular wall and the neocortex. We show that these cells co-express markers for mesenchymal stem cells and pericytes in vivo and in vitro, but do not express glial, neuronal progenitor, hematopoietic, endothelial or microglial markers in their native state. Furthermore, we demonstrate at a clonal level that these progenitors have true multilineage potential towards both, the mesodermal and neuroectodermal phenotype. They can be epigenetically induced in vitro into adipocytes, chondroblasts and osteoblasts but also into glial cells and immature neurons. This progenitor population exhibits long-term proliferation, karyotype stability and retention of phenotype and multipotency following extensive propagation. Thus, we provide evidence that the vascular niche in the adult human brain harbors a novel progenitor with multilineage capacity that appears to represent mesenchymal stem cells and is different from any previously described human neural stem cell. Future studies will elucidate whether these cells may play a role for disease or may represent a reservoir that can be exploited in efforts to repair the diseased human brain.
Introduction
Mesenchymal stem cells (MSC) are the conceptual postnatal progenitors of most derivatives of mesoderm [1, 2] . They were initially isolated from the bone marrow [3] , but subsequently also from several other tissues e.g. the umbilical cord, bone trabeculae, muscle, synovium, dental pulp, periodontal ligament and adipose tissue [1, 4] . Mesenchymal stem cells are isolated by adherence to plastic, and characterized by the expression of a panel of surface markers [5] and their capacity to differentiate along mesodermal lineages into adipocytes, chondroblasts and osteoblasts [3] . Until recently, the exact in vivo identity of MSC was elusive. However, now it has been suggested that MSC may reside in the perivascular compartment and have characteristics identical to a subclass of pericytes [4, 6, 7, 8] . Pericytes reside on the abluminal surface of endothelial cells in the perivascular space and span the entire microvasculature. Not only are they important regulators of angiogenesis and blood vessel function [9] they also contribute to the pathogenesis of diabetic microangiopathy, cancer, atherosclerosis and Alzheimer's disease [10] . Akin to MSC, pericytes have been reported to be able to differentiate into osteoblasts [11, 12] , chondrocytes and adipocytes [13, 14] . Observations in several tissues suggest that they can contribute to tissue repair: pericytes differentiate into adipocytes during fat tissue injury [15] , into chondroblasts and bone after bone injury [12] , into myoblasts in a model for muscular dystrophy [16] and into Leydig cells of the testis [17] . Recent data in a mouse model show that pericytes have the ability to contribute to spinal cord repair by differentiation into astrocytes [18] . Interestingly, the highest density of pericytes is found in the central nervous system [19] and it is not known whether the human perivascular compartment harbors this particular subclass of pericytes and whether this cell type has stem cell properties.
Here, for the first time, we identify a perivascular stem cell in the human adult brain. We isolate, purify and characterize cells from human brain biopsies that resemble marker expression of the perivascular progenitors found in vivo. We show that these cells share a mesenchymal and pericyte phenotype and have the potential to differentiate into mesodermal and neuroectodermal progeny.
Results

The adult human brain contains cells that co-express mesenchymal and pericyte markers
We examined sections of the human neocortex for the presence of cells expressing MSC markers. Cells positive for a-smooth muscle antigen (a-SMA), a marker for smooth muscle cells and pericytes [20] lined microcapillaries ( Figure 1A ). We identified cells expressing the pericyte marker platelet-derived growth factor receptor b (PDGFR-b) along the perivascular space [21, 22] . A subpopulation of PDGFR-b-positive pericytes co-expressed markers for MSC (CD105 and CD13) and was preferably situated at vessel branching points ( Figure 1B, C) . The PDGFR-b-positive pericytes located at the branching point of vessels also expressed Ki67, a marker associated with cell proliferation ( Figure 1D ). Interestingly, also the cells labeling for MSC markers were found at branching points, suggesting that this is a proliferating population. We therefore refer to these cells as perivascular MSC hereafter.
Isolation, sorting and expansion of human mesenchymal progenitor cells
Fresh tissue biopsies from the ventricular zone or the temporal neocortex of the human brain were carefully enzymatically dissociated, plated on plastic dishes and subjected to Fluorescence-activated cell sorting (FACS) once high enough cell numbers had been obtained (Figure 2A, B) . Within a few days after plating the first proliferating adherent cells were visible ( Figure 2C ). Only very few primary neural cells or cell aggregates were visible in freshly plated cultures but were lost when the cell cultures had been passaged twice. Passaging and replating on uncoated plastic dishes selected for the adherent cell type ( Figure 2D , E).
Cell lines from both the ventricular zone and the cortex exhibited similar logarithmic growth expansion ( Figure 2F ) and could be freeze-stored and thawed without losing their proliferation capacity. We were able to efficiently long-term propagate cells over many passages (up to passage 50 assessed so far). Longterm expanded cells kept a normal karyotype ( Figure 2G ).
We used FACS to purify the cells. We sorted cell lines from all donors by first positively gating for MSC markers CD13 and CD105; and then negatively for the hematopoietic marker CD45 and the endothelial marker CD31. The CD13 + CD105 + CD45 2 CD31 2 population comprised 99.4-100% of the isolated and propagated cell populations irrespective of which donor they originated from and whether they were derived from the ventricular zone or the neocortex ( Figure 3A-D) . Based on the marker expression found in vitro we concluded that the isolated cells resemble the perivascular MSC in vivo.
Co-expression of mesenchymal and pericyte markers
We further investigated the antigenic profile of the cell lines using flow cytometry analysis. Cell lines from all donors (n = 4) expressed several MSC markers, such as CD105 (98.98% 60.5), CD73 (96.0% 62.9), CD90 (88.5% 65.2), CD29 (99.4% 60.2), CD166 (96.0% 62.4) and CD49d (89.2% 64.1) but not the myoblast marker CD56 (4.4% 60.8) (Fig. 4A and B) . Furthermore, the cell lines expressed a panel of phenotypic markers currently used to identify pericytes [8, 16] (Fig. 4A, B) .
Consistent with the flow cytometry analysis, using immunocytochemistry we confirmed that cells expressed the pericyte markers PDGFR-b/CD140b, RGS5, NG2 but not the glial precursor marker O4. Cells co-labeled with a-SMA, Nestin and Kir6.1, a marker specific for cerebral pericytes [26] . Results did not differ between donors or region of origin (ventricular zone or neocortex). Representative images from a ventricular donor line are presented ( Figure 5A-E) . Furthermore, proliferating cell lines did not stain for the neural or glial precursor cell markers GLAST (astrocyte-specific glutamate transporter), GFAP, S-100b or A2B5 (data not shown).
Characteristics of clonally derived progenitors
Next, we derived clones from all cell lines to investigate differentiation properties of the brain-derived perivascular MSC ( Figure 6A ). Single cell-derived clones were derived from all donors with minimal variation in cloning efficacy (1-3%). Clones had the same antigenic profile as FACS-sorted polyclonal cells ( Figure 6B ). As cells were derived from the human brain, expanded monoclonal cell lines from all donors were also examined for the presence of mRNA for neural progenitor markers to exclude that the population was derived from a neural progenitor. The human neuronal progenitor line MesC2.10 [27] served as a positive control. Single-cell derived clones expressed high levels of mRNA for pericyte markers RGS5, PDGFR-b and a-SMA compared to the human neuronal progenitors. As expected, clonal lines derived from perivascular MSC and the control neuronal progenitors expressed comparable levels for Nestin and NG2 mRNA ( Figure 6C ). Both, Nestin and NG2 are markers that are described for neuronal progenitors, but are also well-recognized markers for pericytes [24, 25, 28] which explains this overlap in marker mRNA. However, most importantly, mRNA for the neuronal progenitor markers CD133, SOX1, NGN2, PAX6 and Musashi was not detectable in any of the monoclonal lines, but highly expressed in the control neuronal progenitor line ( Figure 6D ).
Clonally derived perivascular MSC differentiate along the mesodermal lineage
The fact that the brain-derived cells expressed MSC and pericyte markers prompted us to investigate their mesodermal potential. Using previously described protocols [8] we successfully induced clonal lines from both the neocortex (n = 6) and the ventricular zone (n = 4) to differentiate into osteoblasts, chondrocytes and adipocytes as evidenced by stainings with the typical markers ( Figure 7A-D) . Control cultures in proliferation medium did not stain for any of the markers (data not shown). Furthermore, we observed a 8-fold upregulation of mRNA for the adipose differentiation related protein (ADRP) in perivascular MSC's cultured in adipogenic medium compared to non-induced control cultures ( Figure 7E ).
Clonally derived perivascular MSC differentiate along the neuroectodermal lineage
Pericytes in different organs share a similar marker expression profile. However, the tissue they reside in may influence their differentiation capacity [7] . Therefore, we investigated if human cerebral perivascular MSC can adopt the phenotype of cells found in the brain.
When clonal cell lines were cultured using a neuronal induction protocol (see methods), mRNA for the neural markers doublecortin (DCX), b-III-tubulin and GFAP was highly upregulated compared to proliferating MSC, thus confirming the neuronal induction ( Figure 8A ). In proliferating, non-induced cultures no mRNA for neuronal markers was detected ( Figure 8A , B). At the same time mRNA for neuronal markers was upregulated in cultures induced in neural induction medium, the expression of the pericyte markers a-SMA, Nestin, RGS5, NG2 and PDGFRb was significantly decreased compared to proliferating controls ( Figure 8B ). This was consistent with the changes in protein expression seen by immunocytochemistry ( Figure 8C ).
We then investigated the expression of mRNA for different neuronal transcription factors. Differentiating cells showed a sixfold upregulation of the neuronal transcription factor Pax6, a twelvefold increase in mRNA for NeuroD1, and a 73-and 42-fold upregulation of Tbr2 and Tbr1, respectively, indicating a glutamatergic phenotype ( Figure 8C ).
Next, we used immunocytochemistry to further investigate the phenotype of differentiated cells. We used two different protocols. When clonal cultures were grown in glial induction medium (see methods) the majority of cells expressed the glial markers GFAP and S100b ( Figure 9A Only very few cells (,1%) adopted a more mature neuronal morphology and expressed GABAA-receptor ( Figure 9I ) but were negative for dopaminergic, serotonergic or cholinergic markers. Neuronal and glial cells could be derived from both regions, i.e. the ventricular zone (4 clones analyzed) and the neocortex (6 clones analyzed).
We then used the patch-clamp technique to examine the electrophysiological properties of clonally derived cells that displayed a neuronal phenotype in comparison to undifferentiated controls. Undifferentiated perivascular progenitor cells were electrically silent under baseline conditions and failed to produce 
Discussion
We have identified a previously uncharacterized multipotent progenitor cell in the perivascular compartment of the adult human brain. Using FACS purification, flow cytometry analysis, immunocytochemistry and qPCR we determine that an isolated progenitor cell exhibits a marker signature for both, MSC and pericytes in vitro.
Perivascular cells and MSC have previously been linked [8, 13, 29] . Recently it was suggested that the in vivo location of MSC may be the perivascular niche and, that MSC may actually represent a subclass of pericytes [6, 7] . Consistent with this notion, we identified cells expressing mesenchymal (CD105, CD13) and pericyte markers (PDGFR-b) in a perivascular location in the adult human brain, primarily around vascular branching points. This population is dividing as indicated by Ki67 staining, a proliferation marker.
We isolate, expand and positively sort the progenitors for CD105 and CD13 and negatively for the hematopoietic marker CD45 and the endothelial CD31. Thereby we show that the isolated and expanded progenitor cells resemble the marker expression of perivascular pericytes in vivo. We further demonstrate that polyclonal and monoclonal cerebral perivascular MSC are highly positive for pericyte and MSC markers but negative for hematopoietic, endothelial, microglial and glial markers. We show that clonally derived cerebral perivascular MSC can differentiate along multiple mesodermal lineages in adipocytes, chondrocytes and osteoblasts. This has not been reported for a human brainderived progenitor cell before, but is a known feature of both MSC from other tissues [3] and pericytes [11, 12, 13, 14] . Neuroectodermal differentiation capacity of MSC has been observed in MSC from bone marrow when cells were exposed to certain epigenetic signals [30, 31, 32, 33, 34] , or when MSC were genetically transduced [35] . Thus, MSC may have an inherent potential to differentiate into multiple lineages if exposed to appropriate epigenetic signals, although this capacity may differ between different tissues of origin. Interestingly, under pathological conditions, a tissue-specific differentiation capacity of pericytes has been observed. Pericytes differentiate into adipocytes during fat tissue injury, or into chondroblasts, bone, myoblasts or Leydig cells, depending on their location [12, 15, 16, 17] . Recently, pericytes have been shown to contribute to spinal cord repair by differentiation into astrocytes [18] . Our findings support previous data in primates and rodents that indicate the possible derivation of neurons from pericytes in the central nervous system. Thus, it was previously suggested that vascular adventitia may generate neural progenitors after transient ischemia in monkeys [36] and another study provided evidence in rats that isolated CNS pericytes have the potential to become cells that express neuronal markers [37] .
We show using PCR and immunocytochemistry that perivascular MSC derived from the human brain not only differentiate into mesodermal lineages, but can be epigenetically induced to differentiate along glial and neuronal lineages. Perivascular MSC change morphology, downregulate pericyte markers and express mRNA for neuronal transcription factors (Pax6, NeuroD1, Tbr2, Tbr1) as well as for doublecortin and TUJ1. We also detect protein expression, though to a low degree, of more mature neuronal markers (HUC/D, NSE, Map2, synaptophysin, GABAA receptor) upon epigenetic simulation. Using a glial induction protocol, cells adopt a glial phenotype and express glial markers (GFAP, S100b, O4). Thus, human cerebral perivascular MSC have the inherent capability to generate glial cells and neuronal cells. The differentiating cells clearly show changes in membrane properties compared to proliferating cells indicating a change in phenotype even though, under the culture conditions we explored, the majority of cells have an immature neuronal phenotype and immature membrane properties. A small percentage of cells express markers resembling the phenotype of mature glutamatergic neurons, consistent with the mRNA expression of neuronal transcription factors. Further studies are warranted to explore whether these cells can be induced into fully mature, long-term surviving, functionally active neurons.
The adult brain harbors neural/glial stem cells in specialized niches [38] . Under physiological conditions, adult neurogenesis occurs mainly in two regions: the subventricular zone and the subgranular zone of the dentate gyrus of the hippocampus [39] . Stem cells in these regions share phenotypical features of radial glia cells or astrocytes expressing GFAP or GLAST [40, 41] . However, neural stem cells have been derived from a variety of other adult brain regions, yet it remains unclear whether these are similar to the neural stem cells found in the subventricular zone and the subgranular zone [42, 43] . Human neural progenitor cells have been isolated from several, also non-neurogenic regions [44, 45, 46, 47] .
The perivascular MSC we isolated differ from those previously described human neural stem cells. First, clonal perivascular MSC from the adult human brain do not express mRNA for neural progenitors such as GFAP, PAX6, Musashi, CD133, SOX1 or NGN2 and do not exhibit early neuronal markers (doublecortin, b-III-tubulin) when proliferating. It is therefore highly unlikely that we have isolated one of the known neuronal or glial human progenitor cell types. Second, the here characterized progenitor population clearly exhibits a perivascular and mesenchymal phenotype. Mesenchymal progenitors locate to the perivascular space, but are not restricted to certain neurogenic brain regions. We could isolate perivascular MSC from biopsies from the ventricular zone and from the neocortex and did not observe any difference in marker expression or differentiation capacity. Third, in contrast to neural stem cells, the isolated perivascular MSC have the capacity for both neuroectodermal and mesodermal differentiation.
The described cerebral perivascular MSC can be efficiently propagated long-term as adherent cultures, they show clonality, have a stable karyotype and retain their full differentiation capacity even following extensive proliferation. Thus, the isolated human cerebral perivascular MSC fulfill the criteria for long-term self-renewing stem cells in vitro [40] .
In conclusion, we have demonstrated the presence of a previously uncharacterized stem cell in vivo in a perivascular location in the human brain. We have shown that these perivascular progenitors share a pericyte and mesenchymal phenotype, that they can be isolated and that single cell-derived clones have the capacity to differentiate along both, mesodermal and neuroectodermal lineages in vitro. The in vivo function of this stem cell, however, is unknown. Future studies will examine its role in the vascular niche in the normal brain and, e.g., how it responds to pathological conditions.
Materials and Methods
Human tissue
All procedures involving human tissue were performed with informed written consent by the patient for the donation of brain tissue and were approved by the ethical committees of the Karolinska Hospital, Stockholm and Scania University Hospital, Lund, Sweden. Brain tissue was harvested from individuals undergoing surgery for ventriculostomy or shunt-placement (n = 2) or surgery for intractable temporal lobe epilepsy (n = 2).
Immunohistochemistry
Cryosections (15 mm) of small human brain cortex pieces were prepared and analyzed as described for human tissue sections [8] .
Isolation and cell culture
Fresh tissue samples were stored in Leibowitz-15 media (Invitrogen) at 4uC, cut and enzymatically digested in enzyme solution (Collagenase 1 mg/ml (Sigma); Dispase 1.6 mg/ml (Roche); Trypsin 0.25 mg/ml (Sigma); DNase I 80 U/ml (Sigma) in Dulbecco's modified Eagle Media (DMEM) and 4.5 mg/ml glucose (Invitrogen) at 37uC/20 min. Cells were plated on 24-well culture dishes and incubated at 37uC/5% CO 2 in DMEM/F-12/ Glutamax/B27 (Invitrogen). Epidermal growth factor (EGF) 20 ng/ml (BD Biosciences), and human basic fibroblast growth factor (bFGF) 20 ng/ml (Invitrogen) were added the day after initial plating. After 7 days, cells were propagated in Stemline medium (Sigma-Aldrich), 2% FBS (Invitrogen), 1% Penicillin/ Streptomycin (P/S) (Gibco) and 1% Glutamax (Gibco). Cells were then expanded on uncoated culture flasks (Corning) without the presence of mitogens.
FACS
For cell sorting, cells were incubated with anti-CD13-PECY7 (BD), anti-CD105-APC (Invitrogen), anti-CD31-FITC (BD), CD45-PE (BD) at the concentration of 20610 6 cells/ml and sorted by FACS (FACSAria; Becton Dickinson) or DIVA software (Becton Dickinson) using a low stream speed to ensure a high level of cell survival and in the four-way purity sorting mode to obtain the highest purity of the sorted cells.
Flow Cytometry
Cultured cells were labeled at different passages with the following commercial antibodies: anti-CD11b-PE, anti-CD14-FITC, anti-CD29-PE-CY5, anti-CD31-FITC, anti-CD34-PerCP, anti-CD45-FITC, anti-CD56-APC, anti-CD49d-PE, anti-CD90-APC, anti-CD140b-PE, anti-CD146-FITC (all Serotec), anti-CD166-PE, anti-CD105 (Invitrogen), anti-CD13-PECY7 and anti-CD73-PE (BD), anti-a-SMA and anti-O4 (Sigma), anti-NG2 (Chemicon), anti-Nestin (Santa Cruz), anti-GFAP Alexa 647, anti-RGS5 (Invitrogen), anti-Kir6.1 (Abcam). Isotype control immunoglobulins used were IgG1-PE, IgG1-FITC, IgG1-APC, IgG1-PercP, IgG1-PECY7 (all from BD). Goat anti-mouse 488 and goat anti-rabbit Alexa 488 were used for non-conjugated primary antibodies. Resuspended cultured cells were stained as follows: For detection of intracellular antigens, cells were fixed with ice-cold methanol (Merck) and permeabilized with 0.05% Saponin (Sigma) when necessary. After washing the cells twice with PBS containing 1% FBS cells were then incubated with the indicated primary antibodies for 30 min on ice. Cells were washed twice, and 10,000 events were acquired on a FACSCalibur (BD).
Cloning
Clonal cell lines were established using limited dilution to 150 cells/ml and 10 ml placed into 48 wells that were inspected for the presence of a single cell 1 h later and supplemented with medium to the total volume of 300 ml. To determine the frequency of clones, single cells were plated into 648 well plates and inspected for presence of single cells as above. Proliferating clones were counted as successful once they could be expanded to a minimum of 250,000 cells.
Differentiation
For glial differentiation, cells were incubated for 10 days in Neurobasal medium (Nb, Invitrogen), LIF (Leukemia inhibitory factor, 10 ng/ml, Chemicon) and CNTF (Ciliary neurotrophic factor, 10 ng/ml, R&D). For neuronal differentiation, cells were grown in Nb medium containing 20 ng/ml PDGF (platelet-derived growth factor) 300 mM, cAMP, 20 ng/ml SHH (sonic hedge hog) and 5 ng/ml FGF2. Medium was supplemented every 48 hrs.
For adipogenesis, cells were grown in DMEM, 10% rabbit serum, 1 mM dexamethasone, 0.5 mM isobutylmethylxanthine, 60 mM indomethacine, and 170 mM insulin (all Sigma). After 14 days, cells QPCR comparing clones derived from the ventricular zone (n = 2), and the cortex (n = 2) to a human neuronal progenitor cell line MesC2.10. Data show the relative higher expression of mRNA for RGS5, PDGFR-b and a-SMA in the MSC clones compared to the control. As expected, Nestin mRNA was present in perivascular MSC clones and neural progenitors at comparable amounts. NG2 mRNA was slightly higher expressed in the MSC clones compared to the control. (D) Importantly, neural progenitors markers such as CD133, SOX1, NGN2, PAX6 and Musashi were highly expressed in the positive control but not detectable in MSC clones. doi:10.1371/journal.pone.0035577.g006 were fixed, washed in 60% isopropanol, and incubated with Oil red O (Sigma) for 10 min at room temperature (RT). For chondrogenesis, 450,000 cells were grown as pellets in serum-free DMEM with insulin-transferrin-selenious (ITS) acid mix (Sigma), 50 mg/ml Lascorbic acid 2-phosphate (WAKO), 100 mg/ml sodium pyruvate (Invitrogen), 0.1 mM dexamethasone (Sigma), and 10 ng/ml transforming growth factor b3 (TGF-b3; R&D). After 21 days, pellets were fixed, frozen, cut into 5 mm sections and stained with Safranin O Red (Sigma). For osteogenesis, cells were cultivated in RPIM, 10% horse serum (Gibco), 0.1 mM dexamethasone, 50 mg/ mL L-ascorbic acid, and 10 mM b-glycerophosphate (Sigma). After 21 days, cells were fixed in ice-cold 70% Ethanol and incubated for 30 min with alizarin red (pH 4.2) for the detection of calcium deposits (all reagents from Sigma-Aldrich) or fixed in 4% PFA and stained with osteocalcin (R&D).
Immunocytochemistry
For immunocytochemistry, cells were plated on glass coverslips that were coated with Poly-L-lysine 90 mg/ml. Cultured cells were fixed 5 min with ice-cold 50% acetone (Sigma Aldrich) and 50% methanol (Fischer Scientific) or with 2% paraformaldehyde (PFA, Sigma) at RT, washed in PBS and incubated for 1 h in PBS, 5% donkey serum (PAA Laboratories). Cultured cells were then stained for both primary and secondary antibodies in the presence of 0.1% Triton X-100 (Sigma) and 2% donkey serum. 
PCR
For real-time qPCR, five-hundred nanograms of total RNA from each sample were used for Oligo(dT) 16 reverse transcription using the AmpliTaq GoldH DNA polymerase first-strand synthesis system for RT-PCR (Applied Biosystems). qPCR reactions with synthesized cDNAs were performed on ABI Prism 7100 (Applied Biosystems) using SYBR Green QPCR Master Mix (Fermentas). mRNA levels were normalized using large ribosomal protein as an internal control. Primer sequences are provided on request.
Karyotyping
Cells from several donors were karyotyped at early, medium and late passage. Cells plated in t25 flasks were harvested using 0.05% trypsin (Sigma, Sweden), and G-banding of chromosomes was obtained with Wright's stain, according to standard procedures. The clonality criteria and the description of the karyotype were according to the recommendations of the ISCN 1995. For each karyotype analyzed, seven different metaphase spreads were examined. Image processing and cell counts Images were acquired using either Olympus BX60, Olympus IX70 or Leica DMRBE fluorescence microscopes. Images were captured with digital cameras (Olympus DP50 and Hamamatsu C4742-95) and processed using studio and Openlab softwares. Confocal microscopy was performed using a Leica microscope equipped with a GreNe and a HeNe laser, using the following lines of excitation: 488 nm, 594 nm and 647 nm. Figures were composed using CANVAS software. Cells were counted in triplicate cultures in randomly chosen areas under the microscope. A minimum of 100 cells/experiment was assessed. Cell numbers are expressed as mean standard deviation (SD).
